The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) is committed to supporting its members and customers throughout the COVID-19 pandemic, recognizing that our goals to improve patient outcomes and relieve the global burden of pain remain as important as ever.

COVID-19 has dramatically affected every aspect of our members' work. ASRA has responded by enhancing engagement, facilitating virtual learning, and continuing to produce those ASRA products that our members find most helpful to their practices. Last spring, we published evidence-based guidance for both regional anesthesia (Figure 1) and interventional pain (Figure 2) procedures within the COVID-19 environment. We debuted educational webinars on topics such as COVID-19, lumbar facet joint guidelines, and opioid use disorder to continue to get this important information out despite the lack of in-person meetings. ASRA launched a...

You do not currently have access to this content.